|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
D'Amico AV: Radiation and hormonal therapy
for locally advanced and clinically localized prostate cancer.
Urology. 60(Suppl 1): 32–37. 2002. View Article : Google Scholar
|
|
3
|
Palumbo C, Bei R, Procopio A and Modesti
A: Molecular targets and targeted therapies for malignant
mesothelioma. Curr Med Chem. 15:855–867. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McNeel DG, Nguyen LD, Storer BE, Vessella
R, Lange PH and Disis ML: Antibody immunity to prostate cancer
associated antigens can be detected in the serum of patients with
prostate cancer. J Urol. 164:1825–1829. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olson BM and McNeel DG: Antibody and
T-cell responses specific for the androgen receptor in patients
with prostate cancer. Prostate. 67:1729–1739. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ronquist KG, Carlsson L, Ronquist G,
Nilsson S and Larsson A: Prostasome-derived proteins capable of
eliciting an immune response in prostate cancer patients. Int J
Cancer. 119:847–853. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Massoner P, Lueking A, Goehler H, et al:
Serum-autoantibodies for discovery of prostate cancer specific
biomarkers. Prostate. 72:427–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agarwal N, Padmanabh S and Vogelzang NJ:
Development of novel immune interventions for prostate cancer. Clin
Genitourin Cancer. 10:84–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mercader M, Bodner BK, Moser MT, et al: T
cell infiltration of the prostate induced by androgen withdrawal in
patients with prostate cancer. Proc Natl Acad Sci USA.
98:14565–14570. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimura S, Yang G, Ebara S, Wheeler TM,
Frolov A and Thompson TC: Reduced infiltration of tumor-associated
macrophages in human prostate cancer: association with cancer
progression. Cancer Res. 60:5857–5861. 2000.PubMed/NCBI
|
|
11
|
Vesalainen S, Lipponen P, Talja M and
Syrjänen K: Histological grade, perineural infiltration,
tumour-infiltrating lymphocytes and apoptosis as determinants of
long-term prognosis in prostatic adenocarcinoma. Eur J Cancer.
30A:1797–1803. 1994. View Article : Google Scholar
|
|
12
|
Gulley JL and Drake CG: Immunotherapy for
prostate cancer: recent advances, lessons learned, and areas for
further research. Clin Cancer Res. 17:3884–3891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nesslinger NJ, Ng A, Tsang KY, Ferrara T,
Schlom J, Gulley JL and Nelson BH: A viral vaccine encoding
prostate-specific antigen induces antigen spreading to a common set
of self-proteins in prostate cancer patients. Clin Cancer Res.
16:4046–4056. 2010. View Article : Google Scholar
|
|
14
|
Becker JT, Olson BM, Johnson LE, Davies
JG, Dunphy EJ and McNeel DG: DNA vaccine encoding prostatic acid
phosphatase (PAP) elicits long-term T-cell responses in patients
with recurrent prostate cancer. J Immunother. 33:639–647. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kantoff PW, Schuetz TJ, Blumenstein BA, et
al: Overall survival analysis of a phase II randomized controlled
trial of a Poxviral-based PSA-targeted immunotherapy in metastatic
castration-resistant prostate cancer. J Clin Oncol. 28:1099–1105.
2010. View Article : Google Scholar
|
|
16
|
Nesslinger NJ, Sahota RA, Stone B, et al:
Standard treatments induce antigen-specific immune responses in
prostate cancer. Clin Cancer Res. 13:1493–1502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koukourakis MI: Radiation damage and
radioprotectants: new concepts in the era of molecular medicine. Br
J Radiol. 85:313–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yarnold J and Brotons MC: Pathogenetic
mechanisms in radiation fibrosis. Radiother Oncol. 97:149–161.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mothersill CE, Moriarty MJ and Seymour CB:
Radiotherapy and the potential exploitation of bystander effects.
Int J Radiat Oncol Biol Phys. 58:575–579. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marzocchella L, Fantini M, Benvenuto M,
Masuelli L, Tresoldi I, Modesti A and Bei R: Dietary flavonoids:
molecular mechanisms of action as anti-inflammatory agents. Recent
Pat Inflamm Allergy Drug Discov. 5:200–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schmid TE and Multhoff G:
Radiation-induced stress proteins-the role of heat shock proteins
(HSP) in anti-tumor responses. Curr Med Chem. 19:1765–1770. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boerma M, van der Wees CG, Vrieling H, et
al: Microarray analysis of gene expression profiles of cardiac
myocytes and fibroblasts after mechanical stress, ionising or
ultraviolet radiation. BMC Genomics. 6:62005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niehoff P, Wiltfang J, Springer IN,
Weppner N, Kimmig B and Acil Y: Increased excretion of collagen
crosslinks in irradiated patients indicates destruction of
collagen. Int J Radiat Biol. 82:503–509. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ehrhart EJ, Gillette EL and Barcellos-Hoff
MH: Immunohistochemical evidence of rapid extracellular matrix
remodeling after iron-particle irradiation of mouse mammary gland.
Radiat Res. 145:157–162. 1996. View
Article : Google Scholar
|
|
25
|
Harriss W, Bezak E, Yeoh E and Hermans M:
Measurement of reoxygenation during fractionated radiotherapy in
head and neck squamous cell carcinoma xenografts. Australas Phys
Eng Sci Med. 33:251–263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Magagnin MG, Sergeant K, van den Beucken
T, et al: Proteomic analysis of gene expression following hypoxia
and reoxygenation reveals proteins involved in the recovery from
endoplasmic reticulum and oxidative stress. Radiother Oncol.
83:340–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Izzi V, Masuelli L, Tresoldi I, Foti C,
Modesti A and Bei R: Immunity and malignant mesothelioma: from
mesothelial cell damage to tumor development and immune
response-based therapies. Cancer Lett. 322:18–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fernandez-Madrid F, Karvonen RL, Kraut MJ,
Czelusniak B and Ager JW: Autoimmunity to collagen in human lung
cancer. Cancer Res. 56:121–126. 1996.PubMed/NCBI
|
|
29
|
Kalluri R, Petrides S, Wilson CB, et al:
Anti-alpha1(IV) collagen autoantibodies associated with lung
adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern
Med. 124:651–653. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tong YQ, Zhang ZJ, Liu B, et al:
Autoantibodies as potential biomarkers for nasopharyngeal
carcinoma. Proteomics. 8:3185–3193. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Young AL, Bailey EE, Colaço SM, Engler DE
and Grossman ME: Anti-laminin-332 mucous membrane pemphigoid
associated with recurrent metastatic prostate carcinoma: hypothesis
for a paraneoplastic phenomenon. Eur J Dermatol. 21:401–404.
2011.
|
|
32
|
Bei R, Masuelli L, Palumbo C, Tresoldi I,
Scardino A and Modesti A: Long-lasting tissue inflammatory
processes trigger autoimmune responses to extracellular matrix
molecules. Int Rev Immunol. 27:137–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bei R, Mentuccia D, Trono P, et al:
Immunity to extracellular matrix antigens is associated with
ultrastructural alterations of the stroma and stratified epithelium
basement membrane in the skin of Hashimotos thyroiditis patients.
Int J Immunopathol Pharmacol. 19:661–674. 2006.
|
|
34
|
Masuelli L, Pompa G, Fabrizi M, et al:
Patients with periimplantitis, unlike those with a healthy
peri-implant microenvironment, display antibodies to more than one
heat shock protein (HSP 27, HSP 65 and HSP 90) linear epitope. Eur
J Inflammation. 9:257–268. 2011.
|
|
35
|
Bei R, Masuelli L, Palumbo C, Modesti M
and Modesti A: A common repertoire of autoantibodies is shared by
cancer and autoimmune disease patients: inflammation in their
induction and impact on tumor growth. Cancer Lett. 281:8–23. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jego G, Hazoumé A, Seigneuric R and
Garrido C: Targeting heat shock proteins in cancer. Cancer Lett.
Nov 13–2010.(Epub ahead of print).
|
|
37
|
Suzuki H, Sugimura H and Hashimoto K:
Overexpression of heat shock protein 27 is associated with good
prognosis in the patient with oral squamous cell carcinoma. Br J
Oral Maxillofac Surg. 45:123–129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wahl MC and Moller W: Structure and
function of the acidic ribosomal stalk proteins. Curr Protein Pept
Sci. 3:93–106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koscec M, Koren E, Wolfson-Reichlin M, et
al: Autoantibodies to ribosomal P proteins penetrate into live
hepatocytes and cause cellular dysfunction in culture. J Immunol.
159:2033–2041. 1997.PubMed/NCBI
|
|
40
|
Mahler M, Kessenbrock K, Szmyrka M, et al:
International multicenter evaluation of autoantibodies to ribosomal
P proteins. Clin Vaccine Immunol. 13:77–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gerli R and Caponi L: Anti-ribosomal P
protein antibodies. Autoimmunity. 38:85–92. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bei R, Masuelli L, Trono P, et al: The
ribosomal P0 protein induces a spontaneous immune response in
patients with head and neck advanced stage carcinoma that is not
dependent on its overexpression in carcinomas. Int J Oncol.
31:1301–1308. 2007.PubMed/NCBI
|
|
43
|
Marzocchella L, Sini V, Buonomo O, et al:
Spontaneous immunogenicity of ribosomal P0 protein in patients with
benign and malignant breast lesions and delay of mammary tumor
growth in P0-vaccinated mice. Cancer Sci. 102:509–515. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun KH, Tang SJ, Lin ML, Wang YS, Sun GH
and Liu WT: Monoclonal antibodies against human ribosomal P
proteins penetrate into living cells and cause apoptosis of Jurkat
T cells in culture. Rheumatology. 40:750–756. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bei R, Masuelli L, Moriconi E, Visco V,
Moretti A, Kraus MH and Muraro R: Immune responses to all ErbB
family receptors detectable in serum of cancer patients. Oncogene.
18:1267–1275. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Masuelli L, Focaccetti C, Cereda V, et al:
Gene-specific inhibition of breast carcinoma in BALB-neuT mice by
active immunization with rat Neu or human ErbB receptors. Int J
Oncol. 30:381–392. 2007.PubMed/NCBI
|
|
47
|
Bei R, Pompa G, Vitolo D, et al:
Co-localization of multiple ErbB receptors in stratified epithelium
of oral squamous cell carcinoma. J Pathol. 195:343–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Masuelli L, Marzocchella L, Focaccetti C,
et al: Local delivery of recombinant vaccinia virus encoding for
neu counteracts growth of mammary tumors more efficiently than
systemic delivery in neu transgenic mice. Cancer Immunol
Immunother. 59:1247–1258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Masuelli L, Marzocchella L, Quaranta A, et
al: Apigenin induces apoptosis and impairs head and neck carcinomas
EGFR/ErbB2 signaling. Front Biosci. 16:1060–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Masuelli L, Bei R, Sacchetti P, et al:
Beta-catenin accumulates in intercalated disks of hypertrophic
cardiomyopathic hearts. Cardiovasc Res. 60:376–387. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Masuelli L, Marzocchella L, Focaccetti C,
et al: Resveratrol and diallyl disulfide enhance curcumin-induced
sarcoma cell apoptosis. Front Biosci. 17:498–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Masuelli L, Budillon A, Marzocchella L, et
al: Caveolin-1 overexpression is associated with simultaneous
abnormal expression of the E-cadherin/α-β catenins complex and
multiple ErbB receptors and with lymph nodes metastasis in head and
neck squamous cell carcinomas. J Cell Physiol. 227:3344–3353.
2012.PubMed/NCBI
|
|
53
|
Bei R, Budillon A, Reale MG, et al:
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune
responses in hepatocellular carcinoma, liver cirrhosis, and chronic
hepatitis patients. Cancer Res. 59:5471–5474. 1999.
|
|
54
|
Turriziani M, Fantini M, Benvenuto M, et
al: Carcinoembryonic antigen (CEA)-based cancer vaccines: recent
patents and antitumor effects from experimental models to clinical
trials. Recent Pat Anticancer Drug Discov. 7:265–296. 2012.
View Article : Google Scholar
|
|
55
|
Bei R and Mizejewski GJ: Alpha fetoprotein
is more than a hepatocellular cancer biomarker: from spontaneous
immune response in cancer patients to the development of an
AFP-based cancer vaccine. Curr Mol Med. 11:564–581. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bei R, Budillon A, Masuelli L, et al:
Frequent overexpression of multiple ErbB receptors by head and neck
squamous cell carcinoma contrasts with rare antibody immunity in
patients. J Pathol. 204:317–325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Scardino A, Alimandi M, Correale P, et al:
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad
range of human and murine CTL effectors to protect against tumor
challenge. Cancer Res. 67:7028–7036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Larsson A, Ronquist G, Wülfing C, et al:
Antiprostasome antibodies: possible serum markers for prostate
cancer metastasizing liability. Urol Oncol. 24:195–200. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hurwitz MD, Kaur P, Nagaraja GM, Bausero
MA, Manola J and Asea A: Radiation therapy induces circulating
serum Hsp72 in patients with prostate cancer. Radiother Oncol.
95:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Knobloch V and Plundrová D:
Immunocomplexes in pregnancy. II. Phagocytosed complexes in the
peripheral blood. Cesk Gynekol. 51:611–616. 1986.(In Czech).
|
|
61
|
Kossenkov AV, Vachani A, Chang C, et al:
Resection of non-small cell lung cancers reverses tumor-induced
gene expression changes in the peripheral immune system. Clin
Cancer Res. 17:5867–5877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Plotz PH: The autoantibody repertoire:
searching for order. Nat Rev Immunol. 3:73–78. 2003. View Article : Google Scholar : PubMed/NCBI
|
